- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03009604
Does Simethicone Improve Operative Field in Gynecological Operations
January 2, 2017 updated by: Altayeb Abd alal Mostafa Mohammad, Assiut University
Mechanical bowel preparation aims to decrease the volume fecal content in the colon, which thereby decreases the total colony count of bacteria, thus, decreasing peritoneal contamination in case of bowel injury, improving the access to the surgical field and facilitating intraoperative bowel manipulation
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Altayeb Mostafa, MBBCh
- Phone Number: 00201003722811
Study Locations
-
-
-
Assiut, Egypt
- Recruiting
- Assiut University
-
Contact:
- Altayeb Mostafa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
Gynecological operations for benign conditions as hysterectomy, ovarian cystectomy and myomectomy.
Exclusion Criteria:
- History of allergic reaction to study drugs.
- More than one scar of previous operation.
- Suspicious of malignancy.
- Psychiatric disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Simethicone
women take 6 tablets (2 tablets after each meal) and to fast overnight before the operation
|
Simethicone 40mg oral tablets
|
Active Comparator: Enema
women take 3 rectal Enema (8:00 pm, 12:00 am & 8:00 am) and to fast over night before the operation.
|
sodium dihydrogen phosphate dihydrate 19.2 gram & disodium hydrogen phosphate dodecahydrate 7.2 gram, in addition to purified water
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the degree of small & large bowel preparation
Time Frame: intraoperative
|
intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2017
Primary Completion (Anticipated)
April 1, 2017
Study Completion (Anticipated)
May 1, 2017
Study Registration Dates
First Submitted
January 2, 2017
First Submitted That Met QC Criteria
January 2, 2017
First Posted (Estimate)
January 4, 2017
Study Record Updates
Last Update Posted (Estimate)
January 4, 2017
Last Update Submitted That Met QC Criteria
January 2, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SIM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Benign Gynecologic Neoplasm
-
University of Campania "Luigi Vanvitelli"CompletedBenign Gynecologic NeoplasmItaly
-
Manipal UniversityCompletedHysterectomy | Benign Gynecologic Neoplasm | Minimal Invasive Surgery
-
Kangbuk Samsung HospitalUnknownBenign Gynecologic NeoplasmKorea, Republic of
-
Hyun ParkRecruiting
-
Massachusetts General HospitalRecruitingMalignant Neoplasm | Benign NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingCancer | Tumor | Benign Neoplasms | Carcinogens | Neoplasm, BenignUnited States
-
Hanyang University Seoul HospitalUnknownBenign Neoplasm | Pathology
-
University Hospital, ToulouseCompletedNeoplasm, Uncertain Whether Benign or MalignantFrance
-
Asan Medical CenterOlympusCompletedBenign Neoplasm of Body of Pancreas | Benign Neoplasm of Tail of Pancreas
-
M.D. Anderson Cancer CenterPharmacia; LifeCellCompletedNeoplasms, GynecologicUnited States
Clinical Trials on Simethicone
-
Lawson Health Research InstituteCompleted
-
Changhai HospitalUnknown
-
Affiliated Hospital to Academy of Military Medical...Completed
-
Asan Medical CenterGE HealthcareCompletedColorectal NeoplasmsKorea, Republic of
-
Chiang Mai UniversityCompletedSterility, PostpartumThailand
-
Changhai HospitalTongji Hospital; Qilu Hospital of Shandong University; First Affiliated Hospital... and other collaboratorsCompletedAdenoma Detection Rate | Bowel Preparation Scale | the Amount of Air BubbleChina
-
University of ManitobaCompleted
-
University of Nevada, RenoGastroenterology ConsultantsCompletedColonoscopyUnited States
-
Xian-Janssen Pharmaceutical Ltd.Completed
-
Portuguese Oncology Institute, CoimbraCompletedColonic Neoplasms | Colo-rectal CancerPortugal